Moncef Slaoui at an Operation Warp Speed press conference on Jan. 12, 2021 (Patrick Semansky/AP Images, Pool)

November 25, 2024 02:37 PM ESTUpdated 02:57 PM

Trump team asked Warp Speed leader to head NIH, may seek more traditional pick for role

Andrew Dunn

Senior Biopharma Correspondent

The transition team for President-elect Donald Trump was still searching for its next National Institutes of Health director as recently as last week, multiple sources …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Trump team asked Warp Speed leader to head NIH, may seek more traditional pick for role

Andrew Dunn

Senior Biopharma Correspondent

Sign up to read this article for free.

Trump taps Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, surgeon general picks

Incyte touts Monjuvi data from Phase 3 follicular lymphoma trial as it heads to FDA

Cassava shares plunge as controversial Alzheimer’s drug fails Phase 3 trial

Biohaven's myostatin inhibitor misses primary endpoint in spinal muscular atrophy trial

Gilead buys experimental HIV vaccines from a small Barcelona biotech

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Andrew Dunn

Senior Biopharma Correspondent

Sign up to read this article for free.

more like this

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Cas­sa­va shares plunge as con­tro­ver­sial Alzheimer’s drug fails Phase 3 tri­al

Bio­haven's myo­statin in­hibitor miss­es pri­ma­ry end­point in spinal mus­cu­lar at­ro­phy tri­al

Gilead buys ex­per­i­men­tal HIV vac­cines from a small Barcelona biotech

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Trump team asked Warp Speed leader to head NIH, may seek more traditional pick for role

Trump taps Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, surgeon general picks

Incyte touts Monjuvi data from Phase 3 follicular lymphoma trial as it heads to FDA

Cassava shares plunge as controversial Alzheimer’s drug fails Phase 3 trial

Biohaven's myostatin inhibitor misses primary endpoint in spinal muscular atrophy trial

Gilead buys experimental HIV vaccines from a small Barcelona biotech

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam